We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs

By LabMedica International staff writers
Posted on 28 Sep 2026

Demand for next-generation sequencing (NGS) continues to rise as laboratories process growing sample volumes, yet library preparation remains labor-intensive and a frequent source of variability. Extended hands-on time can constrain throughput and delay reporting, especially in targeted sequencing workflows. A new automation option now streamlines NGS library preparation steps to improve consistency and turnaround.

OGT, a Sysmex Group company, has introduced automation capabilities across its SureSeq next‑generation sequencing portfolio, designed for use with the Hamilton NGS STAR Line. Announced in Oxford, UK, in September 2026, the update targets high‑volume environments where maintaining throughput and meeting turnaround time goals are critical. The automation offering extends ongoing investment in SureSeq workflows.


Image: OGT\'s SureSeq next‑generation sequencing portfolio, designed for use with the Hamilton NGS STAR Line (Photo courtesy of Hamilton Company)
Image: OGT\'s SureSeq next‑generation sequencing portfolio, designed for use with the Hamilton NGS STAR Line (Photo courtesy of Hamilton Company)

According to OGT, the automation-enabled SureSeq workflows remove manual intervention at the most time‑consuming stages of NGS library preparation. By minimizing hands‑on steps, the system supports high‑throughput processing across multiple sample types and is intended to deliver faster, more consistent results without additional resource burden. Developed in close collaboration with laboratory partners and workflow specialists, the approach focuses on reproducibility and scalability in routine operations.

The automation is positioned to complement OGT’s hematological malignancy‑focused SureSeq panels, including the recently launched SureSeq Myeloid MRD Plus NGS Panel, for laboratories seeking streamlined targeted sequencing. The company frames the development within broader pressures on clinical research labs, where rising volumes have made manual library preparation a growing bottleneck.

“NGS automation is essential for high-volume labs to get the most out of their NGS analysis. By removing labour-intensive manual steps, labs can dramatically increase capacity, improve reproducibility and consistency, allowing them to focus their teams where it matters most,” said Adrian Smith, CEO of OGT.

Related Links
OGT
Hamilton Company


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Hematology Consumables
Bioblood Devices

Latest Technology News

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
28 Sep 2026  |   Technology

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
28 Sep 2026  |   Technology

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
28 Sep 2026  |   Technology